SUMER JACQUELYN L 4
4 · Cullinan Therapeutics, Inc. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
SUMER JACQUELYN L
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-12-18$11.41/sh−3,482$39,730→ 90,651 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.